Lonza Potelligent CHOK1SV host cell line
Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
The cell line retains the features of a high-productivity cell line (robust, high-yielding, scalable) and the bioprocess platform for CHOK1SV is repeatable in the new cell line.
Antibodies produced by the new cell line: exhibit enhanced antibody dependent cellular cytotoxicity (ADCC) even with the low-ADCC allotype of CD16, overcoming CD16 polymorphism; can exert potent cytotoxic effects when their target antigen is low; work in whole blood; and retain required features of antibodies, such as Protein A binding.
Phone: 1300 657508
Biosensis GAPDH antibodies
Biosensis offers two types of GAPDH antibodies: a mouse monoclonal antibody (Cat #M-1376) and a...
Enzo Life Sciences SCREEN-WELL Hematopoietic Toxicity Library
The library is a focused collection of 115 compounds with defined and diverse haematopoietic...
Cytek 24-Color Mouse Immunoprofiling Panel
The panel enables users to efficiently identify and characterise multiple lineage subsets in...
